Page 7 - Sanford Burnham Prebys News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The addition of both Dr. Brenner and Dr. Blouw substantially expands Plus internal expertise in key areas Dr. Brenner will maintain his academic commitments but will greatly contribute to Plus’ scientific and clinical efforts to develop targeted radiotherapeutics for central nervous system (CNS) cancers Dr. Blouw is an expert in CNS tumor biology and in the diagnosis of neoplasms of the cerebrospinal fluid AUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) Plus Therapeutics, Inc. (Nasdaq: PSTV) (

United statesSan diego divisionSan antonioSb kolitz ctrc zachryCorey davisBarbara blouwAndrew brennerMarch hedrickSanford burnham prebysUtrecht universityCompany as viceUniversity of californiaTexasam universitySan diego division of biological sciencesDiscovery instituteOncology research